Logotype for Dabur India Limited

Dabur India (DABUR) Q3 25/26 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Dabur India Limited

Q3 25/26 earnings summary

3 Feb, 2026

Executive summary

  • Q3 FY26 consolidated revenue grew 6.1% year-over-year, with India FMCG up 6% and international revenue up 11.1% in INR terms.

  • Operating profit rose 7.7% and PAT increased 10.1% year-over-year; adjusted PAT growth was 7.2% excluding a one-time labor law provision.

  • Market share gains across key categories, with strong double-digit growth in Amla, Real Activ, Dabur Honey, Dabur Honitus, health juices, and Meswak.

  • Interim dividend of ₹2.75 per share (₹487.76 crores) was paid during the quarter.

  • Faced headwinds from input cost escalation, inventory liquidation due to revised GST, and international market disruptions.

Financial highlights

  • Consolidated revenue from operations for Q3 FY26 was ₹3,558.65 crores, up from ₹3,355.25 crores in Q3 FY25.

  • Operating profit increased to ₹734.1 crore (20.6% margin), and EBITDA rose to ₹874.8 crore (24.6% margin).

  • Net profit before exceptional items was ₹575.0 crore, up 10.1% year-over-year; consolidated net profit after exceptional items was ₹553.61 crores.

  • Standalone revenue for Q3 FY26 was ₹2,547.39 crores, with net profit at ₹439.40 crores.

  • Basic EPS (consolidated) for Q3 FY26 was ₹3.16, up from ₹2.95 in Q3 FY25.

Outlook and guidance

  • Management expects sequential demand recovery, high single-digit top-line growth in Q4, and year-over-year EBITDA margin expansion.

  • FY27 growth is expected to be high single-digit, primarily volume-led, with some price increases and operating margin improvement.

  • Focus remains on market share gains, innovation, premiumization, and brand building.

  • Board and management highlighted continued growth in both revenue and profit, with positive operating and net profit margins.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more